Table 1. Top 10 association signals in the GGRI TS GWAS follow-up study (609 cases and 610 ancestry-matched controls).
TS GWAS | GGRI sample | Meta-analysis | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
CHR | SNP | BP (hg19) | A1/A2 | MAF | OR | P | OR | P | OR | P | Gene | eQTL/mQTL |
12 | rs2060546 | 96,215,456 | A/G | 0.027 | 1.60 | 3.7×10−4 | 2.41 | 3.3×10−4 | 1.77 | 5.8×10−7 | SNRPF|NTN4|CCDC38 | |
2 | rs1922786 | 58,863,573 | G/A | 0.35 | 0.83 | 2.1×10−4 | 0.76 | 2.4×10−3 | 0.81 | 1.9×10−6 | SEL1L2, LMAN1L, INSL3 | |
9 | rs7868992 | 116,991,071 | G/A | 0.28 | 1.29 | 1.9×10−6 | 1.11 | 0.26 | 1.24 | 6.4×10−6 | COL27A1 | SYTL4, AMBP, HSPC152, OAS2, PWP1, RALBP1 |
11 | rs11603305 | 10,997,949 | G/A | 0.28 | 1.27 | 1.3×10−5 | 1.16 | 0.10 | 1.24 | 7.2×10−6 | ||
7 | rs1882078 | 37,436,975 | C/T | 0.28 | 1.27 | 1.9×10−5 | 1.15 | 0.11 | 1.23 | 1.1×10−5 | ELMO1 | |
12 | rs6539267 | 106,785,554 | C/T | 0.31 | 0.79 | 7.4×10−6 | 0.90 | 0.22 | 0.82 | 1.1×10−5 | TCP11L2|POLR3B | TMEM119 |
7 | rs769111 | 12,059,806 | G/T | 0.38 | 0.81 | 1.2×10−5 | 0.90 | 0.19 | 0.83 | 1.6×10−5 | MEOX2, PLSCR1, PCDHB16 | |
11 | rs7123010 | 86,341,186 | A/G | 0.30 | 0.79 | 4.2×10−5 | 0.89 | 0.20 | 0.82 | 4.9×10−5 | ME3 | NFKBIZ, FLJ23514, KLF8, PICALM |
11 | rs621942 | 85,783,738 | A/C | 0.24 | 1.23 | 1.3×10−4 | 1.15 | 0.14 | 1.21 | 6.8×10−5 | PICALM | TMEM126B, TMEM126A, PICALM, CREB3L3, LRRC2 |
3 | rs2282755 | 50,442,800 | T/G | 0.28 | 0.80 | 5.6×10−5 | 0.90 | 0.24 | 0.82 | 7×10−5 | TMEM115|CACNA2D2 | ZMYND10, PTH1R, HYAL3, SEMA3G |
CHR, Chromosome; BP (hg19), Physical position according to NCBI Build 37/hg19 genome assembly; A1/A2, Allele 1/Allele 2 (Allele 1 is the minor allele); MAF, Minor Allele Frequency; OR, odds ratio; P, p-value of genetic association test; eQTL/mQTL, SNP associated with gene expression levels (cerebellum or frontal cortex) and/or methylation levels in cerebellum (as described in Scharf et al. 2013). Complete results of all 42 targeted SNPs are provided in Table S3.